DEA faces Marijuana Legal Scrutiny
Cannabis News
April 8, 2024
Patients suffer as DEA delays Marijuana clinical trials. DEA’s mandate is drug diversion, security and to facilitate drug development? Immediately, MMJ filed for relief in Rhode Island federal court, seeking an order to halt the DEA’s unconstitutional actions. The trial focused on the DEA’s apparent
Read More: DEA faces Marijuana Legal Scrutiny



Comments are closed, but trackbacks and pingbacks are open.